Inhibition of hepatitis C virus NS3 helicase by manoalide

Kazi Abdus Salam, Atsushi Furuta, Naohiro Noda, Satoshi Tsuneda, Yuji Sekiguchi, Atsuya Yamashita, Kohji Moriishi, Masamichi Nakakoshi, Masayoshi Tsubuki, Hidenori Tani, Junichi Tanaka, Nobuyoshi Akimitsu

    Research output: Contribution to journalArticle

    23 Citations (Scopus)

    Abstract

    The hepatitis C virus (HCV) causes one of the most prevalent chronic infectious diseases in the world, hepatitis C, which ultimately develops into liver cancer through cirrhosis. The NS3 protein of HCV possesses nucleoside triphosphatase (NTPase) and RNA helicase activities. As both activities are essential for viral replication, NS3 is proposed as an ideal target for antiviral drug development. In this study, we identified manoalide (1) from marine sponge extracts as an RNA helicase inhibitor using a high-throughput screening photoinduced electron transfer (PET) system that we previously developed. Compound 1 inhibits the RNA helicase and ATPase activities of NS3 in a dose-dependent manner, with IC50 values of 15 and 70 μM, respectively. Biochemical kinetic analysis demonstrated that 1 does not affect the apparent Km value (0.31 mM) of NS3 ATPase activity, suggesting that 1 acts as a noncompetitive inhibitor. The binding of NS3 to single-stranded RNA was inhibited by 1. Manoalide (1) also has the ability to inhibit the ATPase activity of human DHX36/RHAU, a putative RNA helicase. Taken together, we conclude that 1 inhibits the ATPase, RNA binding, and helicase activities of NS3 by targeting the helicase core domain conserved in both HCV NS3 and DHX36/RHAU.

    Original languageEnglish
    Pages (from-to)650-654
    Number of pages5
    JournalJournal of Natural Products
    Volume75
    Issue number4
    DOIs
    Publication statusPublished - 2012 Apr 27

    Fingerprint

    RNA Helicases
    Viruses
    Hepacivirus
    Adenosine Triphosphatases
    Nucleoside-Triphosphatase
    RNA
    Liver
    Antiviral Agents
    Porifera
    Liver Neoplasms
    Hepatitis C
    Screening
    Human Activities
    Throughput
    Inhibitory Concentration 50
    Communicable Diseases
    Fibrosis
    Chronic Disease
    Kinetics
    manoalide

    ASJC Scopus subject areas

    • Complementary and alternative medicine
    • Molecular Medicine
    • Organic Chemistry
    • Analytical Chemistry
    • Pharmaceutical Science
    • Pharmacology
    • Drug Discovery

    Cite this

    Salam, K. A., Furuta, A., Noda, N., Tsuneda, S., Sekiguchi, Y., Yamashita, A., ... Akimitsu, N. (2012). Inhibition of hepatitis C virus NS3 helicase by manoalide. Journal of Natural Products, 75(4), 650-654. https://doi.org/10.1021/np200883s

    Inhibition of hepatitis C virus NS3 helicase by manoalide. / Salam, Kazi Abdus; Furuta, Atsushi; Noda, Naohiro; Tsuneda, Satoshi; Sekiguchi, Yuji; Yamashita, Atsuya; Moriishi, Kohji; Nakakoshi, Masamichi; Tsubuki, Masayoshi; Tani, Hidenori; Tanaka, Junichi; Akimitsu, Nobuyoshi.

    In: Journal of Natural Products, Vol. 75, No. 4, 27.04.2012, p. 650-654.

    Research output: Contribution to journalArticle

    Salam, KA, Furuta, A, Noda, N, Tsuneda, S, Sekiguchi, Y, Yamashita, A, Moriishi, K, Nakakoshi, M, Tsubuki, M, Tani, H, Tanaka, J & Akimitsu, N 2012, 'Inhibition of hepatitis C virus NS3 helicase by manoalide', Journal of Natural Products, vol. 75, no. 4, pp. 650-654. https://doi.org/10.1021/np200883s
    Salam KA, Furuta A, Noda N, Tsuneda S, Sekiguchi Y, Yamashita A et al. Inhibition of hepatitis C virus NS3 helicase by manoalide. Journal of Natural Products. 2012 Apr 27;75(4):650-654. https://doi.org/10.1021/np200883s
    Salam, Kazi Abdus ; Furuta, Atsushi ; Noda, Naohiro ; Tsuneda, Satoshi ; Sekiguchi, Yuji ; Yamashita, Atsuya ; Moriishi, Kohji ; Nakakoshi, Masamichi ; Tsubuki, Masayoshi ; Tani, Hidenori ; Tanaka, Junichi ; Akimitsu, Nobuyoshi. / Inhibition of hepatitis C virus NS3 helicase by manoalide. In: Journal of Natural Products. 2012 ; Vol. 75, No. 4. pp. 650-654.
    @article{fecac5d7cf0540e18173ecc0993403fd,
    title = "Inhibition of hepatitis C virus NS3 helicase by manoalide",
    abstract = "The hepatitis C virus (HCV) causes one of the most prevalent chronic infectious diseases in the world, hepatitis C, which ultimately develops into liver cancer through cirrhosis. The NS3 protein of HCV possesses nucleoside triphosphatase (NTPase) and RNA helicase activities. As both activities are essential for viral replication, NS3 is proposed as an ideal target for antiviral drug development. In this study, we identified manoalide (1) from marine sponge extracts as an RNA helicase inhibitor using a high-throughput screening photoinduced electron transfer (PET) system that we previously developed. Compound 1 inhibits the RNA helicase and ATPase activities of NS3 in a dose-dependent manner, with IC50 values of 15 and 70 μM, respectively. Biochemical kinetic analysis demonstrated that 1 does not affect the apparent Km value (0.31 mM) of NS3 ATPase activity, suggesting that 1 acts as a noncompetitive inhibitor. The binding of NS3 to single-stranded RNA was inhibited by 1. Manoalide (1) also has the ability to inhibit the ATPase activity of human DHX36/RHAU, a putative RNA helicase. Taken together, we conclude that 1 inhibits the ATPase, RNA binding, and helicase activities of NS3 by targeting the helicase core domain conserved in both HCV NS3 and DHX36/RHAU.",
    author = "Salam, {Kazi Abdus} and Atsushi Furuta and Naohiro Noda and Satoshi Tsuneda and Yuji Sekiguchi and Atsuya Yamashita and Kohji Moriishi and Masamichi Nakakoshi and Masayoshi Tsubuki and Hidenori Tani and Junichi Tanaka and Nobuyoshi Akimitsu",
    year = "2012",
    month = "4",
    day = "27",
    doi = "10.1021/np200883s",
    language = "English",
    volume = "75",
    pages = "650--654",
    journal = "Journal of Natural Products",
    issn = "0163-3864",
    publisher = "American Chemical Society",
    number = "4",

    }

    TY - JOUR

    T1 - Inhibition of hepatitis C virus NS3 helicase by manoalide

    AU - Salam, Kazi Abdus

    AU - Furuta, Atsushi

    AU - Noda, Naohiro

    AU - Tsuneda, Satoshi

    AU - Sekiguchi, Yuji

    AU - Yamashita, Atsuya

    AU - Moriishi, Kohji

    AU - Nakakoshi, Masamichi

    AU - Tsubuki, Masayoshi

    AU - Tani, Hidenori

    AU - Tanaka, Junichi

    AU - Akimitsu, Nobuyoshi

    PY - 2012/4/27

    Y1 - 2012/4/27

    N2 - The hepatitis C virus (HCV) causes one of the most prevalent chronic infectious diseases in the world, hepatitis C, which ultimately develops into liver cancer through cirrhosis. The NS3 protein of HCV possesses nucleoside triphosphatase (NTPase) and RNA helicase activities. As both activities are essential for viral replication, NS3 is proposed as an ideal target for antiviral drug development. In this study, we identified manoalide (1) from marine sponge extracts as an RNA helicase inhibitor using a high-throughput screening photoinduced electron transfer (PET) system that we previously developed. Compound 1 inhibits the RNA helicase and ATPase activities of NS3 in a dose-dependent manner, with IC50 values of 15 and 70 μM, respectively. Biochemical kinetic analysis demonstrated that 1 does not affect the apparent Km value (0.31 mM) of NS3 ATPase activity, suggesting that 1 acts as a noncompetitive inhibitor. The binding of NS3 to single-stranded RNA was inhibited by 1. Manoalide (1) also has the ability to inhibit the ATPase activity of human DHX36/RHAU, a putative RNA helicase. Taken together, we conclude that 1 inhibits the ATPase, RNA binding, and helicase activities of NS3 by targeting the helicase core domain conserved in both HCV NS3 and DHX36/RHAU.

    AB - The hepatitis C virus (HCV) causes one of the most prevalent chronic infectious diseases in the world, hepatitis C, which ultimately develops into liver cancer through cirrhosis. The NS3 protein of HCV possesses nucleoside triphosphatase (NTPase) and RNA helicase activities. As both activities are essential for viral replication, NS3 is proposed as an ideal target for antiviral drug development. In this study, we identified manoalide (1) from marine sponge extracts as an RNA helicase inhibitor using a high-throughput screening photoinduced electron transfer (PET) system that we previously developed. Compound 1 inhibits the RNA helicase and ATPase activities of NS3 in a dose-dependent manner, with IC50 values of 15 and 70 μM, respectively. Biochemical kinetic analysis demonstrated that 1 does not affect the apparent Km value (0.31 mM) of NS3 ATPase activity, suggesting that 1 acts as a noncompetitive inhibitor. The binding of NS3 to single-stranded RNA was inhibited by 1. Manoalide (1) also has the ability to inhibit the ATPase activity of human DHX36/RHAU, a putative RNA helicase. Taken together, we conclude that 1 inhibits the ATPase, RNA binding, and helicase activities of NS3 by targeting the helicase core domain conserved in both HCV NS3 and DHX36/RHAU.

    UR - http://www.scopus.com/inward/record.url?scp=84860329960&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84860329960&partnerID=8YFLogxK

    U2 - 10.1021/np200883s

    DO - 10.1021/np200883s

    M3 - Article

    C2 - 22394195

    AN - SCOPUS:84860329960

    VL - 75

    SP - 650

    EP - 654

    JO - Journal of Natural Products

    JF - Journal of Natural Products

    SN - 0163-3864

    IS - 4

    ER -